GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (OTCPK:ABCZF) » Definitions » Additional Paid-In Capital

Abcam (ABCZF) Additional Paid-In Capital : $340.2 Mil(As of Jun. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Abcam Additional Paid-In Capital?


Abcam's quarterly additional paid-in capital declined from Jun. 2022 ($331.2 Mil) to Dec. 2022 ($328.1 Mil) but then increased from Dec. 2022 ($328.1 Mil) to Jun. 2023 ($340.2 Mil).

Abcam's annual additional paid-in capital increased from Jun. 2019 ($34.2 Mil) to Jun. 2020 ($173.0 Mil) and increased from Jun. 2020 ($173.0 Mil) to Dec. 2022 ($328.1 Mil).

Abcam Additional Paid-In Capital Historical Data

The historical data trend for Abcam's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Additional Paid-In Capital Chart

Abcam Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.60 34.04 34.22 172.97 328.14

Abcam Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 356.32 372.37 331.16 328.14 340.15

Abcam Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Abcam Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Abcam's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Abcam (ABCZF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (OTCPK:ABCZF) » Definitions » Additional Paid-In Capital
Comparable Companies
ACAD CRSP HALO RVMD BPMC NUVL MDGL INSM PCVX FOLD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
N/A
Address
Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX
Website
https://www.abcam.com
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.